A Machine Built for Rocks
In the 1980s, extracorporeal shockwave lithotripsy (ESWL) revolutionised urology. For the first time, kidney stones could be fragmented without surgery — using nothing but focused pressure waves generated outside the body.
The machines were large, expensive, and powerful. But they worked. Millions of patients avoided the operating table.
The Unexpected Discovery
Engineers and clinicians noticed something remarkable: the tissues surrounding the kidney stones showed accelerated healing. Blood vessels proliferated. Inflammation decreased. The pressure pulses were doing more than breaking rocks — they were triggering biological repair.
This observation sparked a decades-long research programme that would eventually lead to CellSonic and VIPP technology.
Smaller, Faster, Smarter
Prof. Andrew Hague recognised that the key to unlocking medical potential was not in making machines more powerful, but in making the switching faster. The result was VIPP — Very Intense Pressure Pulse — technology that delivers three simultaneous forces:
- Pressure waves penetrating deep into tissue
- Therapeutic light energy promoting cellular repair
- Electrical field at 25,000 volts influencing cell membrane potential
30+ Conditions and Growing
Today, CellSonic treats chronic wounds, non-union fractures, nerve damage, plantar fasciitis, tendinopathy, psoriasis, periodontal disease, and has pioneered innovative applications in reversing chronic disease through cell voltage restoration.
The journey from kidney stones to cancer treatment is a testament to the power of observation, engineering innovation, and a willingness to challenge the boundaries of conventional medicine.
Learn more about the technology behind CellSonic VIPP.
